666 related articles for article (PubMed ID: 9242714)
1. Multisite regulation of insulin secretion by cAMP-increasing agonists: evidence that glucagon-like peptide 1 and glucagon act via distinct receptors.
Gromada J; Ding WG; Barg S; Renström E; Rorsman P
Pflugers Arch; 1997 Sep; 434(5):515-24. PubMed ID: 9242714
[TBL] [Abstract][Full Text] [Related]
2. Glucagon-like peptide 1 (7-36) amide stimulates exocytosis in human pancreatic beta-cells by both proximal and distal regulatory steps in stimulus-secretion coupling.
Gromada J; Bokvist K; Ding WG; Holst JJ; Nielsen JH; Rorsman P
Diabetes; 1998 Jan; 47(1):57-65. PubMed ID: 9421375
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase A-dependent stimulation of exocytosis in mouse pancreatic beta-cells by glucose-dependent insulinotropic polypeptide.
Ding WG; Gromada J
Diabetes; 1997 Apr; 46(4):615-21. PubMed ID: 9075801
[TBL] [Abstract][Full Text] [Related]
4. Imidazoline NNC77-0074 stimulates insulin secretion and inhibits glucagon release by control of Ca(2+)-dependent exocytosis in pancreatic alpha- and beta-cells.
Høy M; Olsen HL; Andersen HS; Bokvist K; Buschard K; Hansen J; Jacobsen P; Petersen JS; Rorsman P; Gromada J
Eur J Pharmacol; 2003 Apr; 466(1-2):213-21. PubMed ID: 12679159
[TBL] [Abstract][Full Text] [Related]
5. SUR1 regulates PKA-independent cAMP-induced granule priming in mouse pancreatic B-cells.
Eliasson L; Ma X; Renström E; Barg S; Berggren PO; Galvanovskis J; Gromada J; Jing X; Lundquist I; Salehi A; Sewing S; Rorsman P
J Gen Physiol; 2003 Mar; 121(3):181-97. PubMed ID: 12601083
[TBL] [Abstract][Full Text] [Related]
6. Glucagon-like peptide I and glucose-dependent insulinotropic polypeptide stimulate Ca2+-induced secretion in rat alpha-cells by a protein kinase A-mediated mechanism.
Ding WG; Renström E; Rorsman P; Buschard K; Gromada J
Diabetes; 1997 May; 46(5):792-800. PubMed ID: 9133546
[TBL] [Abstract][Full Text] [Related]
7. New insights concerning the glucose-dependent insulin secretagogue action of glucagon-like peptide-1 in pancreatic beta-cells.
Holz GG
Horm Metab Res; 2004; 36(11-12):787-94. PubMed ID: 15655710
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide I increases cytoplasmic calcium in insulin-secreting beta TC3-cells by enhancement of intracellular calcium mobilization.
Gromada J; Dissing S; Bokvist K; Renström E; Frøkjaer-Jensen J; Wulff BS; Rorsman P
Diabetes; 1995 Jul; 44(7):767-74. PubMed ID: 7789644
[TBL] [Abstract][Full Text] [Related]
9. Glucagon-like peptide 1 potentiates glucotoxicity-diminished insulin secretion via stimulation of cAMP-PKA signaling in INS-1E cells and mouse islets.
Luo G; Kong X; Lu L; Xu X; Wang H; Ma X
Int J Biochem Cell Biol; 2013 Feb; 45(2):483-90. PubMed ID: 23220045
[TBL] [Abstract][Full Text] [Related]
10. Glucagon stimulates exocytosis in mouse and rat pancreatic alpha-cells by binding to glucagon receptors.
Ma X; Zhang Y; Gromada J; Sewing S; Berggren PO; Buschard K; Salehi A; Vikman J; Rorsman P; Eliasson L
Mol Endocrinol; 2005 Jan; 19(1):198-212. PubMed ID: 15459251
[TBL] [Abstract][Full Text] [Related]
11. The role of the free cytosolic calcium level in beta-cell signal transduction by gastric inhibitory polypeptide and glucagon-like peptide I(7-37).
Lu M; Wheeler MB; Leng XH; Boyd AE
Endocrinology; 1993 Jan; 132(1):94-100. PubMed ID: 8380389
[TBL] [Abstract][Full Text] [Related]
12. Dual glucagon recognition by pancreatic beta-cells via glucagon and glucagon-like peptide 1 receptors.
Moens K; Flamez D; Van Schravendijk C; Ling Z; Pipeleers D; Schuit F
Diabetes; 1998 Jan; 47(1):66-72. PubMed ID: 9421376
[TBL] [Abstract][Full Text] [Related]
13. GLP-1(7-36) amide stimulates insulin secretion in rat islets: studies on the mode of action.
Fridolf T; Ahrén B
Diabetes Res; 1991 Apr; 16(4):185-91. PubMed ID: 1802486
[TBL] [Abstract][Full Text] [Related]
14. GLP-I(7-36) amide augments Ba2+ current through L-type Ca2+ channel of rat pancreatic beta-cell in a cAMP-dependent manner.
Suga S; Kanno T; Nakano K; Takeo T; Dobashi Y; Wakui M
Diabetes; 1997 Nov; 46(11):1755-60. PubMed ID: 9356022
[TBL] [Abstract][Full Text] [Related]
15. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.
Göke R; Fehmann HC; Linn T; Schmidt H; Krause M; Eng J; Göke B
J Biol Chem; 1993 Sep; 268(26):19650-5. PubMed ID: 8396143
[TBL] [Abstract][Full Text] [Related]
16. Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells.
Salapatek AM; MacDonald PE; Gaisano HY; Wheeler MB
Mol Endocrinol; 1999 Aug; 13(8):1305-17. PubMed ID: 10446905
[TBL] [Abstract][Full Text] [Related]
17. Glucagon-like peptide-1 induces a cAMP-dependent increase of [Na+]i associated with insulin secretion in pancreatic beta-cells.
Miura Y; Matsui H
Am J Physiol Endocrinol Metab; 2003 Nov; 285(5):E1001-9. PubMed ID: 14534075
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide-1-(7-36)amide and a rise in cyclic adenosine 3',5'-monophosphate increase cytosolic free Ca2+ in rat pancreatic beta-cells by enhancing Ca2+ channel activity.
Yada T; Itoh K; Nakata M
Endocrinology; 1993 Oct; 133(4):1685-92. PubMed ID: 8404610
[TBL] [Abstract][Full Text] [Related]
19. Glucose-dependent stimulatory effect of glucagon-like peptide 1(7-36) amide on the electrical activity of pancreatic beta-cells recorded in vivo.
Fernandez J; Valdeolmillos M
Diabetes; 1999 Apr; 48(4):754-7. PubMed ID: 10102691
[TBL] [Abstract][Full Text] [Related]
20. Glucagon-like peptide 1 elevates cytosolic calcium in pancreatic beta-cells independently of protein kinase A.
Bode HP; Moormann B; Dabew R; Göke B
Endocrinology; 1999 Sep; 140(9):3919-27. PubMed ID: 10465260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]